Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
glucagon-like peptide-1 (1 trial)
sodium chloride (1 trial)
Critical Illness (Phase 2)
Hypoglycemia (Phase 2)
Trials (1 total)
Trial APIs (2 total)